Charles River utilizes a truly integrated approach to small molecule drug discovery, uniting all of the key disciplines required to achieve a program's goals in a single project team. As an experienced drug discovery organization, we are able to tailor project resources to meet the client's specific needs, integrating chemistry, physical sciences, CADD, biology, structural biology, ADMET/PK and disease models as required.

Webinar Replay

New Strategy to Identify Small Molecule Therapies: Usher III Syndrome Case Study

Watch now »

I need to...